Imunon, Inc. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
Imunon, Inc. (IMNN) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 1.37% for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-11.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2016-03-30
- Imunon, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2015-03-31 was 1.37%, a 953.85% increase year-over-year.
- Imunon, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2014-03-31 was 0.13%, a 83.12% decline year-over-year.
- Imunon, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2013-03-31 was 0.77%.
- Imunon, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2011-12-31 was 0.83%.
- Imunon, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2013 was 0.13%, a 82.19% decline from fiscal 2012.
- Imunon, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2012 was 0.73%, a 12.05% decline from fiscal 2011.
- Imunon, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2011 was 0.83%, a 58.91% decline from fiscal 2010.
- Imunon, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2010 was 2.02%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 1 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2015-03-31 | 1.37% 10-Q · filed 2015-05-11 | ||||
| 2014-03-31 | 0.13% 10-Q · filed 2014-05-08 | ||||
| 2013-12-31 | 0.13% 10-K · filed 2016-03-30 | ||||
| 2013-03-31 | 0.77% 10-Q · filed 2013-05-09 | ||||
| 2012-12-31 | 1.10% 10-K · filed 2013-03-18 | 0.73% 10-K · filed 2015-03-12 | |||
| 2012-09-30 | 0.62% 10-Q · filed 2012-11-09 | ||||
| 2012-06-30 | 0.73% 10-Q · filed 2012-08-14 | ||||
| 2011-12-31 | 0.83% 10-Q · filed 2012-11-09 | 0.83% 10-K · filed 2013-03-18 | |||
| 2010-12-31 | 2.02% 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |